secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001193125-26-177178
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio launches $75M ATM equity offering after exhausting prior $14.2M program
-------------------------------------------------------------------------------

- Company sold all $14.2M from prior ATM program; offering terminated as of April 24, 2026.
- New prospectus supplement filed for up to $75M in common stock via Cantor Fitzgerald.
- Shares offered under effective shelf registration statement (Form S-3, filed April 2025).
- Goodwin Procter LLP issued legal opinion on the additional shares (Exhibit 5.1).
- No offer or sale in jurisdictions where unregistered or unlawful.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526177178/0001193125-26-177178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526177178/d31430d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-177178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer